Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
82.39
+1.01 (1.24%)
At close: May 18, 2026, 4:00 PM EDT
82.00
-0.39 (-0.47%)
After-hours: May 18, 2026, 7:45 PM EDT
Edwards Lifesciences Stock Forecast
Stock Price Forecast
The 30 analysts that cover Edwards Lifesciences stock have a consensus rating of "Buy" and an average price target of $97.15, which forecasts a 17.91% increase in the stock price over the next year. The lowest target is $84 and the highest is $110.
Price Target: $97.15 (+17.91%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 7 | 7 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 21 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $104 → $110 | Buy | Maintains | $104 → $110 | +33.51% | Apr 27, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $92 → $93 | Buy | Maintains | $92 → $93 | +12.88% | Apr 24, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $89 → $90 | Hold | Maintains | $89 → $90 | +9.24% | Apr 24, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $87 → $85 | Hold | Maintains | $87 → $85 | +3.17% | Apr 24, 2026 |
| BTIG | BTIG | Strong Buy Maintains $98 → $100 | Strong Buy | Maintains | $98 → $100 | +21.37% | Apr 24, 2026 |
Financial Forecast
Revenue This Year
6.94B
from 6.07B
Increased by 14.44%
Revenue Next Year
7.63B
from 6.94B
Increased by 9.88%
EPS This Year
3.07
from 1.83
Increased by 67.61%
EPS Next Year
3.44
from 3.07
Increased by 11.91%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 7.2B | 8.0B | |||||
| Avg | 6.9B | 7.6B | |||||
| Low | 6.5B | 7.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 17.9% | 14.5% | |||||
| Avg | 14.4% | 9.9% | |||||
| Low | 6.9% | 0.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 3.20 | 3.69 | |||||
| Avg | 3.07 | 3.44 | |||||
| Low | 2.30 | 2.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 74.7% | 20.0% | |||||
| Avg | 67.6% | 11.9% | |||||
| Low | 25.6% | -15.8% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.